Take a look at any of these that may interest you:
vjhemonc.com/subject/myelop...
No account/registration is needed to view the videos.
The site does say that it's intended for professionals, but as long as you don't tell, I won't.
Hopefully there is some information there that may help one or more of us...
Best,
PA
Nice set of mini-updates. Thanks for posting.
An example that I found interesting and insightful:
ASH 2023 | Thromboembolic event rates in patients with PV: a real-world analysis
Andrew Kuykendall • 27 Nov 2023 ASH 2023 Myeloproliferative Neoplasms Polycythemia Vera Rare Diseases
Andrew Kuykendall, MD, Moffitt Cancer Center, Tampa, FL, comments on a real-world analysis investigating the rate of thromboembolic events (TEs) in patients with polycythemia vera (PV). This analysis included over 20,000 US patients and took into account TEs prior to and following PV diagnosis. Dr Kuykendall emphasizes that, although patients with prior history of TE were at greatest risk of another event, TE risk is high in all [MPN patients, even those considered ‘low-risk’. Clinicians must continue to focus on decreasing TE risk as the primary treatment goal in PV. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
Cancer Research UK - Information regarding MPN's
Besremi
Covid Antibodies and MPNs
